| DIRECT COMPETITOR COMPARISON | |
| DNDN | ABT | MITI | NWBO.OB | Industry | | Market Cap: | 3.16B | 83.65B | 462.20M | 38.26M | 99.24M | | Employees: | 198 | 69,000 | 104 | 4 | 68 | | Qtrly Rev Growth (yoy): | -3.80% | 3.50% | -42.90% | N/A | 19.70% | | Revenue (ttm): | 108.00K | 29.92B | 22.29M | 10.00K | 14.05M | | Gross Margin (ttm): | 100.00% | 58.31% | -52.17% | 100.00% | 64.07% | | EBITDA (ttm): | -74.09M | 8.64B | -25.92M | -17.02M | -12.30M | | Oper Margins (ttm): | -72,917.59% | 22.32% | -131.32% | -170,270.00% | -158.08% | | Net Income (ttm): | -196.49M | 5.60B | -40.02M | -19.33M | N/A | | EPS (ttm): | -1.915 | 3.691 | -0.742 | -0.446 | -0.33 | | P/E (ttm): | N/A | 14.65 | N/A | N/A | 16.76 | | PEG (5 yr expected): | N/A | 1.27 | N/A | N/A | 1.32 | | P/S (ttm): | 29724.96 | 2.81 | 21.42 | 3470.31 | 9.68 |
|
| ABT = Abbott Laboratories | | MITI = Micromet, Inc. | | NWBO.OB = Northwest Biotherapeutics Inc. | | Industry = Biotechnology | |
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 56.50 | -1.02% | 57.19B | 12.32 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 46.92 | -1.12% | 13.57B | 15.70 | | Genzyme Corp. | GENZ | 51.07 | -0.87% | 13.55B | 29.12 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 46.56 | -0.89% | 41.90B | 18.00 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 49.95 | -1.85% | 8.91B | 1019.39 | | Teva Pharmaceutical Industries Limited | TEVA | 52.88 | -0.53% | 46.59B | 48.38 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 36.96 | -2.25% | 3.92B | 19.05 | | Barr Pharmaceuticals, Inc. | Private - View Profile | | King Pharmaceuticals Inc. | KG | 11.95 | -1.08% | 2.97B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 18.01 | -1.53% | 5.50B | 110.49 | | Pfizer Inc. | PFE | 18.25 | -1.83% | 147.27B | 15.16 | | Johnson & Johnson | JNJ | 62.89 | -0.65% | 173.52B | 13.73 | | GlaxoSmithKline plc | GSK | 42.26 | -1.45% | 107.13B | 13.21 | | Sanofi-Aventis | SNY | 38.43 | -2.61% | 100.35B | N/A |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Novartis AG | NVS | 55.38 | -0.84% | 125.78B | 16.58 | | RHHBY.PK | 41.46 | -1.96% | N/A | N/A | | AstraZeneca plc | AZN | 45.29 | -2.35% | 65.67B | 9.09 | | Abbott Laboratories | ABT | 54.08 | -0.61% | 83.65B | 14.65 | | Bristol-Myers Squibb Co. | BMY | 25.38 | -1.05% | 50.28B | 13.13 |
|
| NEWS ON DIRECT COMPETITORS | |
| • | NWBO.OB | | NORTHWEST BIOTHERAPEUTICS INC Financials
Sat 1:04pm -
EDGAR Online Financials | | • | ABT | | Digital Angiography Pump Monitor Creates Investment Opportunity In Utah Based Small Cap Medical Device Company
Sat 10:28am -
Wall Street Transcript | | • | MITI | | MICROMET, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements and
Fri 5:09pm -
EDGAR Online | | • | ABT | | A Mostly Meaningless FDA Approval
Fri 11:18am -
at Motley Fool | | • | ABT | | INSIDE WASHINGTON: Stream of WH health care visits
Thu, Nov 26 -
AP | | • | ABT | | AP IMPACT: A stream of WH health care visits
Wed, Nov 25 -
AP | | • | ABT | | A Big Upgrade for Amylin Pharmaceuticals
Wed, Nov 25 -
at Motley Fool | | • | MITI | | Micromet Enters Into Agreement With Lonza for the Manufacture of Blinatumomab
Tue, Nov 24 -
GlobeNewswire | | • | NWBO.OB | | NORTHWEST BIOTHERAPEUTICS INC Files SEC form 10-Q, Quarterly Report
Mon, Nov 23 -
EDGAR Online | | • | MITI | | Micromet to Present at The Lazard Capital Markets 6th Annual Healthcare Conference on November 18, 2009
Thu, Nov 12 -
GlobeNewswire | | • | MITI | | MICROMET, INC. Financials
Wed, Nov 11 -
EDGAR Online Financials | | • | MITI | | Micromet Misses Estimates
Mon, Nov 9 -
Zacks.com | | • | MITI | | New Star Analyst Rankings for Micromet, Inc.
Sun, Nov 8 -
StarMine | | • | NWBO.OB | | Long-Term Data Updates Show Further Extensions of Survival and Delays in Recurrence in Brain Cancer Patients Who Received DCVax(R)-Brain
Wed, Oct 21 -
PR Newswire | | • | NWBO.OB | | NORTHWEST BIOTHERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Fi
Mon, Sep 28 -
EDGAR Online | | • | NWBO.OB | | NORTHWEST BIOTHERAPEUTICS INC Files SEC form 10-Q, Quarterly Report
Fri, Aug 14 -
EDGAR Online | | | All Headlines for these symbols... |
|
|
|
1.48% Nasdaq 
Competitors
